Getting Started
Indices
Inflammation
Bone and mineral
Glucose and insulin
Lipids
Nerve and blood vessel
Oxidative stress and fibrosis
Kidney and protein
Cartilage
The CBOAI sums five domains of orthopaedic ageing into one score. It uses 15 biomarkers. A higher score means more of the panel sits outside its healthy range, with the most weight on the domains that matter most for this index.
See Indices for how every index is calculated.
Domains
| Domain | Biomarkers | αd |
|---|---|---|
| Inflammation & Immune Aging (IIA) | hs-CRP, NLR, IL-6 | 6 |
| Endocrine-Mineral Regulation (EMR) | PTH, Ca/P ratio, Vitamin D | 1 |
| Bone & Cartilage Output (BCO) | PINP, CTX-II, Osteocalcin | 1 |
| Muscle-ECM Degeneration (M-ECMD) | CK-MM, Aldolase A, MMP-9, MDA | 5 |
| Neurovascular Coupling (NVC) | VEGF, BDNF | 3 |
αd is the fixed priority of each domain in this index.
Example
These are the results of one example patient, worked through step by step.
Biomarker Z-scores
Each result becomes a Z-score: (value − mean) / SD, with the mean and SD taken from the healthy range.
Inflammation & Immune Aging (IIA)
| Biomarker | Healthy range | Mean | SD | Direction | Value | Z | |Z| |
|---|---|---|---|---|---|---|---|
| hs-CRP | 0.2–3.0 mg·L⁻¹ | 1.6 | 0.7 | ↑ Bad | 3.5 | 2.71 | 2.71 |
| NLR | 1.0–3.0 ratio | 2 | 0.5 | ↑ Bad | 3.2 | 2.40 | 2.40 |
| IL-6 | 0.5–7.0 pg·mL⁻¹ | 3.75 | 1.63 | ↑ Bad | 9.8 | 3.71 | 3.71 |
Endocrine-Mineral Regulation (EMR)
| Biomarker | Healthy range | Mean | SD | Direction | Value | Z | |Z| |
|---|---|---|---|---|---|---|---|
| PTH | 15–65 pg·mL⁻¹ | 40 | 12.5 | ↑ Bad | 75.3 | 2.82 | 2.82 |
| Ca/P ratio | 2.0–2.8 ratio | 2.4 | 0.2 | Normal best | 2.9 | 2.50 | 2.50 |
| Vitamin D | 30–100 ng·mL⁻¹ | 65 | 17.5 | ↓ Bad | 25.4 | -2.26 | 2.26 |
Bone & Cartilage Output (BCO)
| Biomarker | Healthy range | Mean | SD | Direction | Value | Z | |Z| |
|---|---|---|---|---|---|---|---|
| PINP | 20–80 ng·mL⁻¹ | 50 | 15 | ↓ Bad | 9.7 | -2.69 | 2.69 |
| CTX-II | 120–450 pg·mL⁻¹ | 285 | 82.5 | ↑ Bad | 510.7 | 2.74 | 2.74 |
| Osteocalcin | 11–43 ng·mL⁻¹ | 27 | 8 | ↓ Bad | 8.9 | -2.26 | 2.26 |
Muscle-ECM Degeneration (M-ECMD)
| Biomarker | Healthy range | Mean | SD | Direction | Value | Z | |Z| |
|---|---|---|---|---|---|---|---|
| CK-MM | 50–170 U·L⁻¹ | 110 | 30 | ↑ Bad | 190 | 2.67 | 2.67 |
| Aldolase A | 1.2–7.5 U·L⁻¹ | 4.35 | 1.58 | ↑ Bad | 8.5 | 2.63 | 2.63 |
| MMP-9 | 20–140 ng·mL⁻¹ | 80 | 30 | ↑ Bad | 155.8 | 2.53 | 2.53 |
| MDA | 1.0–3.5 µmol·L⁻¹ | 2.25 | 0.63 | ↑ Bad | 4.6 | 3.73 | 3.73 |
Neurovascular Coupling (NVC)
| Biomarker | Healthy range | Mean | SD | Direction | Value | Z | |Z| |
|---|---|---|---|---|---|---|---|
| VEGF | 30–250 pg·mL⁻¹ | 140 | 55 | Context | 305.6 | 3.01 | 3.01 |
| BDNF | 15–40 ng·mL⁻¹ | 27.5 | 6.25 | ↓ Bad | 12.8 | -2.35 | 2.35 |
Domain scores
| Domain | Mean |Z|d | Wd | Mean |Z|d × Wd | αd | Score |
|---|---|---|---|---|---|
| IIA | 2.94 | 0.22 | 0.64 | 6 | 3.82 |
| EMR | 2.53 | 0.19 | 0.47 | 1 | 0.47 |
| BCO | 2.56 | 0.19 | 0.48 | 1 | 0.48 |
| M-ECMD | 2.89 | 0.21 | 0.61 | 5 | 3.07 |
| NVC | 2.68 | 0.20 | 0.53 | 3 | 1.59 |
| Total | 13.60 | 1.00 | 2.73 | 9.42 |
The example patient's CBOAI is 9.42.
Inflammation & Immune Aging adds the most to the score (3.82 of 9.42).
Notes
- The mean and SD come from the healthy range, so a result inside the range has a |Z| of 2 or less.
- The score has no fixed upper limit. Compare it over time for the same person, not between indices.
- This page is general information, not medical advice. Discuss results with a clinician.